ACS CAN presented Medford’s Marina Watanabe with the Young Leader award in recognition of her passionate advocacy and commitment to ending cancer as we know it, for everyone.
MONTGOMERY, Ala. – Patient advocacy groups including the American Cancer Society Cancer Action Network (ACS CAN) and ZERO Prostate Cancer applaud Alabama State Sen.
More than 100 organizations representing millions of patients with serious health conditions and health care professionals sent a letter to Congress expressing their strong support for the Clinical Trial Modernization Act. Introduced in the House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-FL), the bipartisan legislation would help remove cost and geographic barriers to patient participation in clinical trials.
Massachusetts cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine and patient navigation for all communities.
Legislation aimed at increasing access to breast and cervical cancer screening was introduced today in the U.S. Senate. The bipartisan Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for fiscal years 2026 through 2030.
New federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House of Representatives. Sponsored by U.S. Reps. Raul Ruiz (D-Calif.) and August Pfluger (R-Texas), the Clinical Trial Modernization Act would help remove cost and geographic hurdles that prevent patients from participating in clinical trials.
With Friday marking the end of the legislative session in Hawai’i, cancer survivors, patients, and advocates with the American Cancer Society Cancer Action Network (ACS CAN) commend the state legislature for committing to health equity by passing a bill that enables researchers to study why cancer disproportionately impacts Native Hawaiians, Pacific Islanders, and Asian Americans including Filipinos in Hawai’i.
Survivors and oncology professionals share their stories with lawmakers to underscore the importance of insurance coverage of cutting-edge biomarker testing
Insurance coverage of biomarker testing will reduce health disparities for cancer patients & improve outcomes across broad spectrum of serious disease
Lawmakers asked to reduce barriers to care and reduce prescription related costs